Literature DB >> 8765451

Non-typhoidal Salmonella bacteraemia: clinical features and risk factors.

V Thamlikitkul1, C Dhiraputra, T Paisarnsinsup, C Chareandee.   

Abstract

A case control study was conducted to determine the risk factors of non-typhoidal Salmonella bacteraemia. Eighty adult patients with non-typhoidal Salmonella bacteraemia admitted to Siriraj Hospital from January to December 1993 served as the cases. The controls comprised 3 groups: group 1, 80 adult in-patients with Escherichia coli bacteraemia; group 2, 80 adult in-patients who did not have bacteraemia and had been admitted to the hospital during the same period as the cases; group 3, 80 in-patients who did not have Salmonella bacteraemia and matched the cases in terms of gender, age, hospital services and admission date. AIDS and corticosteroid use were the major risk factors for acquiring non-typhoidal Salmonella bacteraemia with an odds ratio of 7.27 to 12.31 (95% confidence interval of 3.39 to 29.40). Almost all patients with non-typhoidal Salmonella bacteraemia presented with a fever for a median duration of 7 days. AIDS patients usually had concomitant opportunistic infections. Salmonella group D was the most common serogroup. Most patients were treated with co-trimoxazole, quinolones, ceftriaxone and ampicillin. Localized suppurative complications were observed in 14% of the patients; the overall mortality rate was 36.3%, 12% of whom died prior to receiving appropriate antibiotics for Salmonella.

Entities:  

Mesh:

Year:  1996        PMID: 8765451     DOI: 10.1046/j.1365-3156.1996.d01-92.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

Review 1.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 2.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

3.  Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut.

Authors:  Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

4.  Non-typhoidal salmonella (NTS) bacteraemia in Malawian adults: a severe, recrudescent, HIV-associated illness.

Authors:  Melita A Gordon; Hastings T Banda; Macpherson Gondwe; Stephen B Gordon; Amanda L Walsh; Amos Phiri; Charles F Gilks; C Anthony Hart; Malcolm E Molyneux
Journal:  Malawi Med J       Date:  2003-06       Impact factor: 0.875

5.  Characterization of Salmonella enterica serovar Enteritidis isolates recovered from blood and stool specimens in Thailand.

Authors:  Rene S Hendriksen; Eija Hyytia-Trees; Chaiwat Pulsrikarn; Srirat Pornruangwong; Phattharaporn Chaichana; Christina Aaby Svendsen; Rafiq Ahmed; Matthew Mikoleit
Journal:  BMC Microbiol       Date:  2012-06-06       Impact factor: 3.605

6.  Epidemiology and antimicrobial resistance of invasive non-typhoidal Salmonellosis in rural Thailand from 2006-2014.

Authors:  Toni Whistler; Patranuch Sapchookul; David W McCormick; Ornuma Sangwichian; Possawat Jorakate; Sirirat Makprasert; Anchalee Jatapai; Sathapana Naorat; Uraiwan Surin; Surathinee Koosakunwat; Surachai Supcharassaeng; Barameht Piralam; Mathew Mikoleit; Henry C Baggett; Julia Rhodes; Christopher J Gregory
Journal:  PLoS Negl Trop Dis       Date:  2018-08-06

7.  Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis.

Authors:  Christian S Marchello; Megan Birkhold; John A Crump
Journal:  Lancet Infect Dis       Date:  2022-02-01       Impact factor: 71.421

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.